FR12C0005I2 - Use of an estrogen-progestogen composition as an oral contraceptive - Google Patents
Use of an estrogen-progestogen composition as an oral contraceptiveInfo
- Publication number
- FR12C0005I2 FR12C0005I2 FR12C0005C FR12C0005C FR12C0005I2 FR 12C0005 I2 FR12C0005 I2 FR 12C0005I2 FR 12C0005 C FR12C0005 C FR 12C0005C FR 12C0005 C FR12C0005 C FR 12C0005C FR 12C0005 I2 FR12C0005 I2 FR 12C0005I2
- Authority
- FR
- France
- Prior art keywords
- estrogen
- oral contraceptive
- progestogen composition
- progestogen
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9612239A FR2754179B1 (en) | 1996-10-08 | 1996-10-08 | NOVEL HORMONONAL COMPOSITION AND ITS USE |
EP97944940A EP0956022B1 (en) | 1996-10-08 | 1997-10-08 | Hormonal composition consisting of an oestrogen compound and of a progestational compound |
Publications (2)
Publication Number | Publication Date |
---|---|
FR12C0005I1 FR12C0005I1 (en) | 2012-02-24 |
FR12C0005I2 true FR12C0005I2 (en) | 2016-06-24 |
Family
ID=9496456
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9612239A Expired - Fee Related FR2754179B1 (en) | 1996-10-08 | 1996-10-08 | NOVEL HORMONONAL COMPOSITION AND ITS USE |
FR12C0005C Active FR12C0005I2 (en) | 1996-10-08 | 2012-01-19 | Use of an estrogen-progestogen composition as an oral contraceptive |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9612239A Expired - Fee Related FR2754179B1 (en) | 1996-10-08 | 1996-10-08 | NOVEL HORMONONAL COMPOSITION AND ITS USE |
Country Status (38)
Country | Link |
---|---|
US (4) | US6831073B1 (en) |
EP (2) | EP0956022B1 (en) |
JP (1) | JP4883542B2 (en) |
KR (2) | KR20000048981A (en) |
CN (3) | CN1239893A (en) |
AP (1) | AP1171A (en) |
AR (2) | AR009113A1 (en) |
AT (2) | ATE353652T1 (en) |
AU (1) | AU745571B2 (en) |
BR (1) | BR9712274A (en) |
CA (1) | CA2268358C (en) |
CL (1) | CL2011000017A1 (en) |
CZ (1) | CZ298402B6 (en) |
DE (3) | DE69737373T2 (en) |
DK (2) | DK1334725T3 (en) |
DZ (1) | DZ2327A1 (en) |
ES (2) | ES2282539T3 (en) |
FR (2) | FR2754179B1 (en) |
HK (1) | HK1210708A1 (en) |
HU (2) | HU227450B1 (en) |
ID (1) | ID21569A (en) |
IL (1) | IL129194A (en) |
LU (1) | LU91932I2 (en) |
MA (1) | MA24370A1 (en) |
MY (1) | MY128482A (en) |
NO (3) | NO324357B1 (en) |
NZ (1) | NZ334876A (en) |
OA (1) | OA11033A (en) |
PL (1) | PL192979B1 (en) |
PT (2) | PT1334725E (en) |
RU (1) | RU2274450C2 (en) |
SK (2) | SK285056B6 (en) |
TN (1) | TNSN97164A1 (en) |
TR (1) | TR199900764T2 (en) |
TW (1) | TW491704B (en) |
WO (1) | WO1998015279A1 (en) |
YU (1) | YU18099A (en) |
ZA (1) | ZA979011B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4344462C2 (en) | 1993-12-22 | 1996-02-01 | Schering Ag | Composition for contraception |
DE19549264A1 (en) * | 1995-12-23 | 1997-06-26 | Schering Ag | Contraception procedure and kit |
FR2754179B1 (en) | 1996-10-08 | 1998-12-24 | Theramex | NOVEL HORMONONAL COMPOSITION AND ITS USE |
WO2001030355A1 (en) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
WO2001030356A1 (en) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Hormonal composition based on a progestational agent and an oestrogen and use thereof |
FR2814074B1 (en) * | 2000-09-15 | 2003-03-07 | Theramex | NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT |
FR2823976A1 (en) * | 2001-04-25 | 2002-10-31 | Theramex | NOVEL HORMONAL COMPOSITION AND ITS USE |
UY29185A1 (en) * | 2004-11-02 | 2006-05-31 | Schering Ag | SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE |
PE20081895A1 (en) | 2007-03-26 | 2009-01-26 | Theramex | ORAL CONTRACEPTIVE REGIME |
US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
US8741329B2 (en) * | 2007-09-21 | 2014-06-03 | Merck Sharp & Dohme B.V. | Drug delivery system |
US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
US10596103B2 (en) | 2013-12-11 | 2020-03-24 | Merek Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
KR20240005348A (en) | 2022-07-05 | 2024-01-12 | 신규식 | System For Trading and Managing Patent |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271392A (en) * | 1965-09-14 | 1966-09-06 | American Home Prod | 17alpha-[3'-furyl]-estrogens |
US4390531A (en) | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4921843A (en) | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
JPS61243059A (en) * | 1985-04-19 | 1986-10-29 | Konishi Kagaku Kogyo Kk | Production of high-purity 4-4'-dihydroxydiphenyl-sulfone |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
ZA87332B (en) | 1986-02-27 | 1987-08-26 | Warner Lambert Co | Compositions containing fixed combinations |
DK174724B1 (en) | 1986-07-15 | 2003-10-06 | Wyeth Corp | Use of a composition comprising an estrogen and a progestogen for the preparation of a dosage form to provide hormone replacement therapy and contraception for women during the premenopause and pack to provide the composition |
CA1332227C (en) | 1987-09-24 | 1994-10-04 | Robert F. Casper | Oral contraceptive formulation |
EP0559240B1 (en) * | 1987-09-24 | 2001-12-05 | Jencap Research Limited | Contraceptive packages containing oestrogen and progestin |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
US5256421A (en) * | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
HUT52382A (en) | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
IE62665B1 (en) | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
FR2695826B1 (en) * | 1992-09-21 | 1995-01-06 | Theramex | New pharmaceutical compositions based on nomegestrol derivatives and methods for obtaining them. |
US6150343A (en) | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
DE4344462C2 (en) * | 1993-12-22 | 1996-02-01 | Schering Ag | Composition for contraception |
US5552394A (en) * | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
US6613757B1 (en) | 1994-09-22 | 2003-09-02 | Board Of Regents, The University Of Texas System | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
SE9403389D0 (en) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivatives of sex hormones |
FR2737411B1 (en) | 1995-08-01 | 1997-10-17 | Theramex | NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES |
DE19540253C2 (en) | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Multi-phase preparation for contraception based on natural estrogens |
DE19549264A1 (en) | 1995-12-23 | 1997-06-26 | Schering Ag | Contraception procedure and kit |
AU2926897A (en) | 1996-05-08 | 1997-11-26 | American Home Products Corporation | Oral contraceptive |
WO1997041869A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1997041871A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1997041868A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1997041872A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
AU3961697A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
AU3888597A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
WO1998004267A1 (en) | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
DE69724796T2 (en) | 1996-07-26 | 2004-07-01 | Wyeth | BIPHASIC ORAL PREVENTION METHOD AND KIT CONTAINING A COMBINATION OF PROGESTINE AND AN ESTROGEN |
NZ333862A (en) | 1996-07-26 | 2000-08-25 | American Home Prod | Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen |
WO2001030355A1 (en) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
FR2754179B1 (en) * | 1996-10-08 | 1998-12-24 | Theramex | NOVEL HORMONONAL COMPOSITION AND ITS USE |
DE19705229C2 (en) | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
EP1007052B1 (en) | 1997-08-27 | 2004-10-13 | Ortho-McNeil Pharmaceutical, Inc. | Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
DE19739916C2 (en) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands |
CN1270521A (en) | 1997-09-12 | 2000-10-18 | 美国家用产品公司 | Oral contraceptive preparation having a first phase comprising comprising progestin/estrogen and a second phase comprising progestin |
WO2001030356A1 (en) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Hormonal composition based on a progestational agent and an oestrogen and use thereof |
-
1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/en not_active Expired - Fee Related
-
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/en unknown
- 1997-10-08 JP JP51726398A patent/JP4883542B2/en not_active Expired - Lifetime
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/en active IP Right Grant
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/en active
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/en unknown
- 1997-10-08 PT PT03008979T patent/PT1334725E/en unknown
- 1997-10-08 PL PL332610A patent/PL192979B1/en unknown
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/en not_active IP Right Cessation
- 1997-10-08 EP EP97944940A patent/EP0956022B1/en not_active Expired - Lifetime
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/en not_active Application Discontinuation
- 1997-10-08 ES ES03008979T patent/ES2282539T3/en not_active Expired - Lifetime
- 1997-10-08 SK SK438-99A patent/SK285056B6/en not_active IP Right Cessation
- 1997-10-08 CN CN97180380A patent/CN1239893A/en active Pending
- 1997-10-08 NZ NZ334876A patent/NZ334876A/en not_active IP Right Cessation
- 1997-10-08 YU YU18099A patent/YU18099A/en unknown
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/en active
- 1997-10-08 ID IDW990211A patent/ID21569A/en unknown
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/en not_active IP Right Cessation
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/en not_active IP Right Cessation
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/en unknown
- 1997-10-08 ES ES97944940T patent/ES2198006T3/en not_active Expired - Lifetime
- 1997-10-08 DK DK03008979T patent/DK1334725T3/en active
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 PT PT97944940T patent/PT956022E/en unknown
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 HU HU9904508A patent/HU227450B1/en active Protection Beyond IP Right Term
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/en active Pending
- 1997-10-08 MA MA24828A patent/MA24370A1/en unknown
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/en active Protection Beyond IP Right Term
- 1997-10-08 AT AT03008979T patent/ATE353652T1/en active
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 EP EP03008979A patent/EP1334725B1/en not_active Expired - Lifetime
- 1997-10-08 DE DE69737373T patent/DE69737373T2/en not_active Expired - Lifetime
- 1997-10-08 CA CA2268358A patent/CA2268358C/en not_active Expired - Lifetime
- 1997-10-08 DE DE69721314T patent/DE69721314T2/en not_active Expired - Lifetime
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/en active Pending
- 1997-10-08 AR ARP970104638A patent/AR009113A1/en not_active Application Discontinuation
- 1997-10-08 IL IL12919497A patent/IL129194A/en not_active IP Right Cessation
- 1997-10-08 DK DK97944940T patent/DK0956022T3/en active
- 1997-10-08 AT AT97944940T patent/ATE238057T1/en active
- 1997-10-15 TW TW086115281A patent/TW491704B/en not_active IP Right Cessation
-
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/en not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/en unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
-
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
-
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
-
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/en not_active Application Discontinuation
-
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/en unknown
-
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/en unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/en active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/en active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/en not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/en unknown
-
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/en unknown
-
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR12C0005I2 (en) | Use of an estrogen-progestogen composition as an oral contraceptive | |
DE19681287T1 (en) | Oral formulation of 2-methylthienobenzodiazepine | |
FI963421A0 (en) | Oral auxiliary compositions | |
BR9509200A (en) | Composition of matter | |
ATE304359T1 (en) | ANTESTROGEN AND PROGESTIN CONTAINING ORAL CONTRACEPTIVES | |
FR2726906B1 (en) | INSTRUMENT OF INDICATION | |
BR9612555A (en) | Detergent compositions containing fragrance precursors and the fragrance precursors of these compositions | |
PT1014987E (en) | ORAL COMPOSITIONS OF LEVOSIMENDANO | |
PT906101E (en) | FORMULATIONS OF PROLONGED LIBERATION CONTAINING MIZOLASTIN | |
ID16838A (en) | COMPOSITION OF DEKAFLUOROPENTANA | |
DE59709372D1 (en) | Fragrance compositions containing substituted 2-acetylbenzofurans | |
DE69528771D1 (en) | IMIDAZOLINE COMPOSITIONS CONTAINING SILICON | |
ID17419A (en) | COMPOSITION OF DEKAFLUOROPENTANA | |
FR2710673B1 (en) | Composition of facing plaster. | |
FR2756310B1 (en) | AUXILIARY AMOUNT OF SCAFFOLDING | |
ID24232A (en) | COMPOSITION OF NON-COROSIVE COOLING MATERIALS | |
MD249F1 (en) | Composition of ingredients for "night" liqueur | |
UA25103A (en) | COMPOSITION OF INGREDIENTS FOR SPECIAL Vodka "ZOLOTE RUSLO" | |
UA25104A (en) | COMPOSITION OF INGREDIENTS FOR SPECIAL "VESILHA" Vodka | |
UA25802A (en) | COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM | |
UA25801A (en) | COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM | |
UA25803A (en) | COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM | |
UA1693S (en) | SET OF LABELS "AMOUNTS" | |
UA2094S (en) | LABEL OF THE MEDICINAL PREPARATION "ASPARKAM" | |
UA1957S (en) | LABEL OF THE MEDICINAL PREPARATION "ASPARKAM" |